IE880250L - Parenteral suspensions - Google Patents

Parenteral suspensions

Info

Publication number
IE880250L
IE880250L IE880250A IE25088A IE880250L IE 880250 L IE880250 L IE 880250L IE 880250 A IE880250 A IE 880250A IE 25088 A IE25088 A IE 25088A IE 880250 L IE880250 L IE 880250L
Authority
IE
Ireland
Prior art keywords
dry formulation
parenteral suspensions
pharmaceutically acceptable
diclofenac
salt
Prior art date
Application number
IE880250A
Other versions
IE60453B1 (en
Inventor
J J Peter Glanzmann
Leo Geller
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IE880250L publication Critical patent/IE880250L/en
Publication of IE60453B1 publication Critical patent/IE60453B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Blow-Moulding Or Thermoforming Of Plastics Or The Like (AREA)

Abstract

4-16314/= Parenteral suspensions The invention relates to a dry formulation, in particular a dry formulation obtainable by lyophilisation, which is suitable for the preparation of a stable, aqueous suspension for the parenteral administration of a diclofenac salt. The dry formulation contains a pharmaceutically acceptable and micronised salt of diclofenac and optional pharmaceutically acceptable adjuvants. [CA1305058C]
IE25088A 1987-01-30 1988-01-29 Parenteral suspensions of diclofenac IE60453B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH350/87A CH673395A5 (en) 1987-01-30 1987-01-30

Publications (2)

Publication Number Publication Date
IE880250L true IE880250L (en) 1988-07-30
IE60453B1 IE60453B1 (en) 1994-07-13

Family

ID=4185019

Family Applications (1)

Application Number Title Priority Date Filing Date
IE25088A IE60453B1 (en) 1987-01-30 1988-01-29 Parenteral suspensions of diclofenac

Country Status (26)

Country Link
JP (1) JPS63192716A (en)
KR (1) KR880008808A (en)
AT (1) AT397460B (en)
AU (1) AU612343B2 (en)
BE (1) BE1000442A4 (en)
CA (1) CA1305058C (en)
CH (1) CH673395A5 (en)
DE (1) DE3802357A1 (en)
DK (1) DK45588A (en)
ES (1) ES2008420A6 (en)
FI (1) FI880368A (en)
FR (1) FR2611498B1 (en)
GB (1) GB2201089B (en)
GR (1) GR880100041A (en)
IE (1) IE60453B1 (en)
IT (1) IT1224241B (en)
LU (1) LU87115A1 (en)
MY (1) MY102662A (en)
NL (1) NL8800231A (en)
NO (1) NO880403L (en)
NZ (1) NZ223343A (en)
PH (1) PH23652A (en)
PT (1) PT86644B (en)
SE (1) SE8800228L (en)
YU (1) YU15488A (en)
ZA (1) ZA88638B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH675537A5 (en) * 1988-03-25 1990-10-15 Ciba Geigy Ag
MX9201782A (en) * 1991-04-19 1992-10-01 Sandoz Ag PARTICLES OF BIOLOGICALLY ACTIVE SUBSTANCES, SUBSTANTIALLY INSOLUBLE IN WATER, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM.
DE4140185C2 (en) * 1991-12-05 1996-02-01 Alfatec Pharma Gmbh Medicament containing a 2-arylpropionic acid derivative in nanosol form and its preparation
DE4140183C2 (en) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Retard form for a medicine containing flurbiprofen
DE4140184C2 (en) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Acute form for a medicine containing flurbiprofen
GB9212450D0 (en) * 1992-06-11 1992-07-22 Indena Spa New derivatives of non-steroidal anti-inflammatory,analgesic and/or antipyretic substances,their use and pharmaceutical formulations containing them
ZA949182B (en) * 1993-12-02 1995-07-26 South African Druggists Ltd Pharmaceutical composition
US6447806B1 (en) 1999-02-25 2002-09-10 Novartis Ag Pharmaceutical compositions comprised of stabilized peptide particles
FR2793418B1 (en) * 1999-05-11 2001-07-27 Synthelabo GALENIC FORMULATIONS OF ANTITHROMBOTIC AGENTS FOR SUBCUTANEOUS ADMINISTRATION
GB0207529D0 (en) * 2002-04-02 2002-05-08 Norbrook Lab Ltd Injectable veterinary composition for small animals
JO3352B1 (en) * 2005-06-17 2019-03-13 Apr Applied Pharma Res Sa Diclofenac formulations and methods of use

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1373913A (en) * 1970-12-17 1974-11-13 Glaxo Lab Ltd Pharmaceutical compositions
DE2914788A1 (en) * 1979-04-11 1980-10-16 Nattermann A & Cie PARENTERAL APPLICABLE, STABLE DRUG SOLUTIONS WITH ANTI-INFLAMMATORY EFFECT
DE3324193A1 (en) * 1983-07-05 1985-01-17 Troponwerke Gmbh & Co Kg DEPOT ANTIPHLOGISTICS
DE3328401A1 (en) * 1983-08-05 1985-02-21 Merckle GmbH, 7902 Blaubeuren INJECTABLE SOLUTION FOR TREATING INFLAMMATION
EP0152379A3 (en) * 1984-02-15 1986-10-29 Ciba-Geigy Ag Process for preparing pharmaceutical compositions containing unilamellar liposomes
DE3421468A1 (en) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim LIPID NANOPELLETS AS A CARRIER SYSTEM FOR MEDICINAL PRODUCTS FOR PERORAL USE
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US5002940A (en) * 1984-11-06 1991-03-26 Ciba-Geigy Corporation Solid drug formulations and stable suspensions
DE3446873A1 (en) * 1984-12-21 1986-07-10 Merckle Gmbh LIQUID DICLOFENAC PREPARATIONS
IT1207994B (en) * 1986-01-03 1989-06-01 Therapicon Srl WATER SOLUBLE SALTS OF ANTI-INFLAMMATORY AND ANALGESIC ADAPTITY COMPOUNDS, THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS.
DE3607339A1 (en) * 1986-03-06 1987-09-10 Merck Patent Gmbh PHARMACEUTICAL PREPARATION

Also Published As

Publication number Publication date
ZA88638B (en) 1989-10-25
AU1110288A (en) 1988-08-04
IE60453B1 (en) 1994-07-13
FI880368A0 (en) 1988-01-27
ES2008420A6 (en) 1989-07-16
DK45588A (en) 1988-07-31
DK45588D0 (en) 1988-01-29
NO880403D0 (en) 1988-01-29
MY102662A (en) 1992-08-17
NO880403L (en) 1988-08-01
FR2611498B1 (en) 1991-06-14
BE1000442A4 (en) 1988-12-06
GB2201089A (en) 1988-08-24
SE8800228D0 (en) 1988-01-25
CH673395A5 (en) 1990-03-15
GR880100041A (en) 1988-12-16
JPS63192716A (en) 1988-08-10
SE8800228L (en) 1988-07-31
IT8847557A0 (en) 1988-08-21
ATA18588A (en) 1993-09-15
AU612343B2 (en) 1991-07-11
LU87115A1 (en) 1989-03-08
PH23652A (en) 1989-09-27
AT397460B (en) 1994-04-25
IT1224241B (en) 1990-09-26
NZ223343A (en) 1990-03-27
GB8801737D0 (en) 1988-02-24
GB2201089B (en) 1990-05-16
FR2611498A1 (en) 1988-09-09
FI880368A (en) 1988-07-31
CA1305058C (en) 1992-07-14
DE3802357A1 (en) 1988-08-11
PT86644B (en) 1992-01-31
KR880008808A (en) 1988-09-13
NL8800231A (en) 1988-08-16
YU15488A (en) 1989-10-31
PT86644A (en) 1988-02-01

Similar Documents

Publication Publication Date Title
IE811911L (en) Suspension-yielding powder
AU599792B2 (en) Anti-parkinsonian indolone derivatives
EP0348808A3 (en) Pharmaceutical formulations and process for preparing them
IE880250L (en) Parenteral suspensions
HU892559D0 (en) Process for the preparation of transdermal pharmaceutical composition suitable for systemic administration, containing deprenyl as active ingredient
CA2053826A1 (en) Pharmaceutical compositions active in the therapy of neurological affections in aids patients
EP0287193A3 (en) Use of nedocromil sodium in the treatment of cystic fibrosis
IE873367L (en) Ranitidine-ethanol formulation
IE894050L (en) Compound with gastric acid inhibitory effect and process for¹its preparation
HUT50334A (en) Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
ES2037095T3 (en) A PROCEDURE FOR PREPARING A PHARMACEUTICAL COMPOSITION.
WO1996022068A3 (en) Methods and pharmaceutical compositions employing desmethylselegiline
EP0388049A3 (en) Derivatives of penciclovir for the treatment of hepatitis-b infections
FI900145A0 (en) Process for the Preparation of Pharmaceutically Useful 1,1-Dioxocephem-4-Carbothiol Acid Derivatives
CA2069296A1 (en) Combination preparation with antithrombotic action
AU7536487A (en) A thymus derivative active after oral administration, methods of preparation and pharmaceutical compositions
CA2015632A1 (en) Stable solutions of rebeccamycin analog and preparations thereof
IE893578L (en) Phenyloxypropanolamine derivatives, their preparation and¹their application in therapeutics
NO172491C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,3-DIOXANE-ALCOHIC ACID DERIVATIVES
RU93005013A (en) 1-AMINOSPIRO [IZOHINOLIN-4 (1H) 3-PYRROLIDIN-1,2,3,5 '(2H) -TETRONS] AND THEIR ANALOGUES, METHOD OF THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITION
EP0363223A3 (en) 3-aryloxymethyl-cephalosporin derivatives, their preparation and their medical use
GR890100737A (en) Preparation method of as pharmaceutical composition for ocular use
CA2022323A1 (en) Excretion of potassium ion by prostanoic acid derivatives
FI93121B (en) Process for the preparation of 5H-pyrido [1 ', 2': 4,5] thiadiazino [2,3-a] benzimidazolium derivatives useful as medicaments
Angehrn Antibacterial composition.

Legal Events

Date Code Title Description
MM4A Patent lapsed